Prognosis of increasing percentages of lesional body surface area in early stage mycosis fungoides
An additional cut-off point of 40% involved BSA has prognostic significance in patients with early patch/plaque-stage MF and may be included in future updates of the clinical staging system. In these patients, systemic therapies should be considered.
Authors
- Juliette M. Kersten (ORCID: https://orcid.org/0009-0005-3142-9656)
- Koen D. Quint (ORCID: https://orcid.org/0000-0002-3267-5630)
- Jelle J. Goeman (ORCID: https://orcid.org/0000-0003-4283-0259)
- Rosanne Ottevanger (ORCID: https://orcid.org/0000-0002-1900-4322)
- Rein Willemze (ORCID: https://orcid.org/0000-0002-4561-7616)
- Julia Scarisbrick (ORCID: https://orcid.org/0000-0002-8011-4408)
- Maarten H. Vermeer (ORCID: https://orcid.org/0000-0002-5872-4613)
- Felicity Evison (ORCID: https://orcid.org/0000-0002-9378-7548)
- Hyun Soo Kim (ORCID: https://orcid.org/0000-0002-2356-7822)
Institutions
- Leiden University Medical Center (NL)
- NIHR Surgical Reconstruction and Microbiology Research Centre (GB)
- Cutaneous Lymphoma Foundation (US)
- Stanford University (US)
Publication Details
- Journal
- Journal of the European Academy of Dermatology and Venereology
- Published
- 2025-05-29
- DOI
- https://doi.org/10.1111/jdv.20773
- Citations
- 5
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 10.02